ÀÛ¼ºÀÏ : 25-07-03 11:19
2025³âµµ ½Å¾à°³¹ß¿¬±¸¼Ò & GIB-RLRC & BK21 °øµ¿ ÁÖÃÖ ¼¼¹Ì³ª ¾È³»
|
|
±Û¾´ÀÌ :
½Å¾à°³¹ß¿¬±¸¼Ò
 Á¶È¸ : 19
|
°¡. Çà »ç ¸í: 2025³âµµ °¿ø´ëÇб³ ½Å¾à°³¹ß¿¬±¸¼Ò & GIB-RLRC & BK21 °øµ¿ ÁÖÃÖ ¼¼¹Ì³ª
³ª. ÀÏ ½Ã: 2025.07.10.(¸ñ) 14:00~16:00
´Ù. Àå ¼Ò: °¿ø´ëÇб³ Çõ½ÅÁ¦¾àÀӻ󿬱¸µ¿ 103È£
¶ó. ÃÊû¿¬»ç ¹× ¹ßÇ¥³»¿ë
1£© Yuji Ito ¹Ú»ç£¨Kagoshima Univ., ÀϺ» Ç×üÇÐȸ ȸÀ壩
- Next-generation ADC by tissue–delivery antibody AccumBody and conjugation technology tCAP
2£© Yoshimasa Tanaka ¹Ú»ç£¨Nagasaki Univ., PD-1/PD-L1 ±â¹Ý ¸é¿ªÇ×¾ÏÁ¦ °³¹ß ¿¬±¸ Âü¿©£©
- Cancer immunotherapy harnessing innate immune cells
¸¶. ÁÖ°ü: °¿ø´ëÇб³ ½Å¾à°³¹ß¿¬±¸¼Ò, GIB-RLRC ¹ÙÀÌ¿À ½Å¾à Çõ½Å¼ÒÀç À¶ÇÕ¼±µµ¿¬±¸¼¾ÅÍ, BK21 ³Ä¡¼ºÁúȯ Çõ½Å½Å¾à °³¹ß ¹Ì·¡ÀÎÀç±³À°¿¬±¸ÆÀ
|
|